ARCHIVES

NABCO to close June 30.

This article is from The Cancer Letter archive.

Vol. 30 No. 05 | January 30, 2004

Download PDF Visit The Full Archive

Related Articles

In Brief: Tom Hall Names CMMI VP For Clinical Affairs; Rabson, Fauci Names to Institute Of Medicine

June 26, 1987

Protocols Approved During The Month of September 2001

October 26, 2001

Clinical Trials Approved By NCI

October 31, 2003

Rosenberg’s Latest Results: 22% Response Seen With LAK/IL-2, 13% With High Dose IL-2 Alone

April 10, 1987

Study: Keytruda Improves PFS In Ipilimumab-Refactory Disease

November 28, 2014

NCI Launches Effort In Cancer Education For Older Americans; Also An ACS Goal, Dodd Tells Writers

March 29, 1991